Global Blood Therapeutics’ $345 Million Notes Offering

Martina Bellini
Tagged:

Goodwin Procter advised Global Blood Therapeutics on the deal.Global Blood Therapeutics, Inc. (Nasdaq: GBT) announced its offering of 1.875% Convertible Senior Notes due 2028. The deal…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now